Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Need for high investment, lack of necessary facilities and the complex nature of the virus make the finding of a vaccine for Ebola a difficult challenge, a noted French microbiologist said here today. "Developing a vaccine is not a trivial issue. It requires huge investments by pharmaceutical companies. So far, Ebola has had limited outbreaks. So there was no need for the community to be convinced that there has to be a vaccine.

  • Two new clinical trials are examining the safety and acceptability of antiretroviral medicines administered via injection as a means of protecting against HIV infection. The studies are being funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and conducted by the NIAID-funded HIV Prevention Trials Network (HPTN).

  • India is an important place to study microbilogoy due to the presence of infectious diseases found in third world countries along with infections that exist in technologically developed countries, a senior French microbiologist today said.

  • Adolescents who get poor or insufficient sleep may be at higher risk of developing alcohol and drug problems, scientists say. Researchers have found that sleep difficulties and hours of sleep can predict a number of specific problems, including binge drinking, driving under the influence of alcohol, and risky sexual behaviour.

  • A new app helps you ‘lend’ your eyes to a visually impaired person and answer their questions over video chat to help them navigate or read a sign.

  • Google is set to discontinue the sale of its smart eyewear Google Glass, but the tech giant plans to release new, consumer-friendly versions of the device in the future. Google has announced that it will no longer sell its experimental first version of Glass which went on sale in the UK last year priced at 1,000 pounds.

  • Elderly women who are satisfied with their lives have a higher bone density and suffer from osteoporosis less frequently than their unsatisfied peers, according to a new study. Bone density gets lower as people age; however, for women, the menopause constitutes a significant risk factor.

  • -- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab)
    -- Inflectra provides an alternative, potentially more affordable treatment option for people suffering from severe, debilitating diseases such as rheumatoid arthritis and inflammatory bowel disease while maintaining comparable quality, efficacy and safety to the reference product

Subscribe to Pharma News